As of 2026-05-27, the EV/EBITDA ratio of Eris Lifesciences Ltd (ERIS.NS) is 18.75. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ERIS.NS's latest enterprise value is 211,521.56 mil INR. ERIS.NS's TTM EBITDA according to its financial statements is 11,278.50 mil INR. Dividing these 2 quantities gives us the above ERIS.NS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 18.1x - 19.9x | 18.6x |
| Forward P/E multiples | 13.5x - 16.4x | 14.8x |
| Fair Price | 1,287.93 - 1,609.69 | 1,388.02 |
| Upside | -5.4% - 18.2% | 2.0% |
| Date | EV/EBITDA |
| 2026-05-22 | 18.54 |
| 2026-05-21 | 19.08 |
| 2026-05-20 | 20.32 |
| 2026-05-19 | 18.64 |
| 2026-05-18 | 18.41 |
| 2026-05-15 | 18.89 |
| 2026-05-14 | 18.80 |
| 2026-05-13 | 18.48 |
| 2026-05-12 | 18.69 |
| 2026-05-11 | 18.92 |
| 2026-05-08 | 19.18 |
| 2026-05-07 | 19.01 |
| 2026-05-06 | 18.92 |
| 2026-05-05 | 18.69 |
| 2026-05-04 | 18.69 |
| 2026-04-30 | 18.26 |
| 2026-04-29 | 18.22 |
| 2026-04-28 | 18.38 |
| 2026-04-27 | 18.72 |
| 2026-04-24 | 18.84 |
| 2026-04-23 | 19.22 |
| 2026-04-22 | 18.57 |
| 2026-04-21 | 18.96 |
| 2026-04-20 | 19.61 |
| 2026-04-17 | 19.79 |
| 2026-04-16 | 20.05 |
| 2026-04-15 | 19.72 |
| 2026-04-13 | 19.11 |
| 2026-04-10 | 18.86 |
| 2026-04-09 | 18.79 |
| 2026-04-08 | 18.67 |
| 2026-04-07 | 18.20 |
| 2026-04-06 | 18.24 |
| 2026-04-02 | 18.39 |
| 2026-04-01 | 18.14 |
| 2026-03-30 | 17.95 |
| 2026-03-27 | 18.55 |
| 2026-03-25 | 18.61 |
| 2026-03-24 | 17.79 |
| 2026-03-23 | 17.91 |
| 2026-03-20 | 18.02 |
| 2026-03-19 | 17.85 |
| 2026-03-18 | 18.06 |
| 2026-03-17 | 17.73 |
| 2026-03-16 | 18.12 |
| 2026-03-13 | 18.42 |
| 2026-03-12 | 18.64 |
| 2026-03-11 | 18.61 |
| 2026-03-10 | 18.71 |
| 2026-03-09 | 18.31 |